Robert W. Baird initiated coverage on Mereo BioPharma with a new price target

6/13/24 7:11:27 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Robert W. Baird initiated coverage of Mereo BioPharma with a rating of Outperform and set a new price target of $8.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$MREO

Date	Price Target	Rating	Analyst
3/27/2025	$7.00	Overweight	Analyst
12/6/2024	$7.00	Buy	Jefferies
6/13/2024	$8.00	Outperform	Robert W. Baird
10/13/2023	$4.00	Buy	BTIG Research
8/12/2022	$4.00	Overweight	Cantor Fitzgerald